Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory A Otterson

Showing results (71-80 of 157) with videos related to

Pageof 16
Sort By:
Molecular and Cellular Biology|March 16, 2006
Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1)Ying Zhao, Shaoli Lu, Lipeng Wu, et al.
International Journal of Environmental Research and Public Health|September 16, 2014
Increased NQO1 but not c-MET and survivin expression in non-small cell lung carcinoma with KRAS mutationsAhmet Yilmaz, Nehad Mohamed, Kara A Patterson, et al.
Molecular Cancer|June 15, 2016
Rad51C-ATXN7 fusion gene expression in colorectal tumorsArjun Kalvala, Li Gao, Brittany Aguila, et al.
Cancer Immunology, Immunotherapy : CII|January 14, 2023
Association between pre-treatment chest imaging and pulmonary function abnormalities and immune checkpoint inhibitor pneumonitisAlex Wong, Maria Riley, Songzhu Zhao, et al.
AJR. American Journal of Roentgenology|October 27, 2015
CT Gray-Level Texture Analysis as a Quantitative Imaging Biomarker of Epidermal Growth Factor Receptor Mutation Status in Adenocarcinoma of the LungEfe Ozkan, Anna West, Jeffrey A Dedelow, et al.
Pharmaceutical Research|May 23, 2006
Nontoxic suramin as a chemosensitizer in patients: dosing nomogram developmentDanny Chen, Sae Heum Song, M Guillaume Wientjes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2006
Assessment of tumor necrosis factor alpha blockade as an intervention to improve tolerability of dose-intensive chemotherapy in cancer patientsJ Paul Monk, Gary Phillips, Ross Waite, et al.
Human Molecular Genetics|March 26, 2003
A comprehensive search for DNA amplification in lung cancer identifies inhibitors of apoptosis cIAP1 and cIAP2 as candidate oncogenesZunyan Dai, Wei-Guo Zhu, Carl D Morrison, et al.
JCO Precision Oncology|February 1, 2022
Economic Impact of Next-Generation Sequencing Versus Single-Gene Testing to Detect Genomic Alterations in Metastatic Non-Small-Cell Lung Cancer Using a Decision Analytic ModelNathan A Pennell, Alex Mutebi, Zheng-Yi Zhou, et al.
Cancer|December 29, 2015
Oncolytic reovirus in combination with chemotherapy in metastatic or recurrent non-small cell lung cancer patients with KRAS-activated tumorsMiguel A Villalona-Calero, Elaine Lam, Gregory A Otterson, et al.
Pageof 16

Showing results (71-80 of 157) with videos related to

Sort By:
Pageof 16
Molecular and Cellular Biology|March 16, 2006
Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1)Ying Zhao, Shaoli Lu, Lipeng Wu, et al.
International Journal of Environmental Research and Public Health|September 16, 2014
Increased NQO1 but not c-MET and survivin expression in non-small cell lung carcinoma with KRAS mutationsAhmet Yilmaz, Nehad Mohamed, Kara A Patterson, et al.
Molecular Cancer|June 15, 2016
Rad51C-ATXN7 fusion gene expression in colorectal tumorsArjun Kalvala, Li Gao, Brittany Aguila, et al.
Cancer Immunology, Immunotherapy : CII|January 14, 2023
Association between pre-treatment chest imaging and pulmonary function abnormalities and immune checkpoint inhibitor pneumonitisAlex Wong, Maria Riley, Songzhu Zhao, et al.
AJR. American Journal of Roentgenology|October 27, 2015
CT Gray-Level Texture Analysis as a Quantitative Imaging Biomarker of Epidermal Growth Factor Receptor Mutation Status in Adenocarcinoma of the LungEfe Ozkan, Anna West, Jeffrey A Dedelow, et al.
Pharmaceutical Research|May 23, 2006
Nontoxic suramin as a chemosensitizer in patients: dosing nomogram developmentDanny Chen, Sae Heum Song, M Guillaume Wientjes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2006
Assessment of tumor necrosis factor alpha blockade as an intervention to improve tolerability of dose-intensive chemotherapy in cancer patientsJ Paul Monk, Gary Phillips, Ross Waite, et al.
Human Molecular Genetics|March 26, 2003
A comprehensive search for DNA amplification in lung cancer identifies inhibitors of apoptosis cIAP1 and cIAP2 as candidate oncogenesZunyan Dai, Wei-Guo Zhu, Carl D Morrison, et al.
JCO Precision Oncology|February 1, 2022
Economic Impact of Next-Generation Sequencing Versus Single-Gene Testing to Detect Genomic Alterations in Metastatic Non-Small-Cell Lung Cancer Using a Decision Analytic ModelNathan A Pennell, Alex Mutebi, Zheng-Yi Zhou, et al.
Cancer|December 29, 2015
Oncolytic reovirus in combination with chemotherapy in metastatic or recurrent non-small cell lung cancer patients with KRAS-activated tumorsMiguel A Villalona-Calero, Elaine Lam, Gregory A Otterson, et al.
Pageof 16